GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,264,000 | +3.4% | 29,044 | +3.6% | 0.78% | +15.6% |
Q1 2022 | $1,222,000 | -1.1% | 28,044 | +1.6% | 0.67% | -3.2% |
Q4 2021 | $1,236,000 | +12.6% | 27,594 | -4.0% | 0.70% | +12.5% |
Q3 2021 | $1,098,000 | -9.1% | 28,744 | -1.8% | 0.62% | -6.9% |
Q2 2021 | $1,208,000 | +9.3% | 29,283 | +1.6% | 0.66% | +3.8% |
Q1 2021 | $1,105,000 | +18.3% | 28,816 | +8.9% | 0.64% | +7.2% |
Q4 2020 | $934,000 | -58.2% | 26,449 | -55.9% | 0.60% | -28.0% |
Q3 2020 | $2,233,000 | +73.5% | 60,019 | +90.2% | 0.83% | -16.1% |
Q2 2020 | $1,287,000 | +4.7% | 31,562 | -2.7% | 0.99% | -17.9% |
Q1 2020 | $1,229,000 | -21.3% | 32,437 | -2.4% | 1.20% | +12.1% |
Q4 2019 | $1,561,000 | +10.6% | 33,227 | +0.5% | 1.07% | +4.1% |
Q3 2019 | $1,411,000 | +6.0% | 33,069 | -0.6% | 1.03% | +6.4% |
Q2 2019 | $1,331,000 | -6.3% | 33,270 | -2.1% | 0.97% | -5.0% |
Q1 2019 | $1,420,000 | +3.0% | 33,978 | -5.8% | 1.02% | -5.0% |
Q4 2018 | $1,379,000 | -4.7% | 36,078 | +0.2% | 1.08% | +11.7% |
Q3 2018 | $1,447,000 | +0.8% | 36,020 | +1.1% | 0.96% | -6.3% |
Q2 2018 | $1,436,000 | +3.0% | 35,620 | -0.1% | 1.03% | -1.5% |
Q1 2018 | $1,394,000 | +10.2% | 35,670 | 0.0% | 1.04% | +20.9% |
Q4 2017 | $1,265,000 | -13.5% | 35,670 | -1.0% | 0.86% | -15.6% |
Q3 2017 | $1,463,000 | -5.6% | 36,030 | +0.2% | 1.02% | -9.0% |
Q2 2017 | $1,550,000 | +2.4% | 35,955 | +0.1% | 1.12% | +0.8% |
Q1 2017 | $1,514,000 | +0.8% | 35,905 | -7.9% | 1.12% | -1.2% |
Q4 2016 | $1,502,000 | -99.9% | 39,005 | +5.3% | 1.13% | -7.6% |
Q3 2016 | $1,597,794,000 | +100516.8% | 37,046 | +1.1% | 1.22% | +1.7% |
Q2 2016 | $1,588,000 | -99.9% | 36,646 | +3.3% | 1.20% | +22.1% |
Q1 2016 | $1,438,349,000 | +0.2% | 35,471 | -0.3% | 0.98% | +2.1% |
Q4 2015 | $1,435,411,000 | +15.6% | 35,574 | +10.2% | 0.96% | +5.7% |
Q3 2015 | $1,241,627,000 | -1.2% | 32,292 | +7.0% | 0.91% | +4.5% |
Q2 2015 | $1,256,622,000 | -11.8% | 30,171 | -2.3% | 0.87% | -11.4% |
Q1 2015 | $1,424,697,000 | +13.0% | 30,871 | +4.7% | 0.98% | +13.2% |
Q4 2014 | $1,260,659,000 | -7.3% | 29,496 | -0.3% | 0.87% | -10.7% |
Q3 2014 | $1,359,379,000 | -14.6% | 29,571 | -0.7% | 0.97% | -14.0% |
Q2 2014 | $1,592,260,000 | +0.1% | 29,773 | +0.0% | 1.13% | -0.4% |
Q1 2014 | $1,590,344,000 | -1.6% | 29,765 | -1.7% | 1.14% | -14.1% |
Q4 2013 | $1,615,848,000 | +2.6% | 30,265 | -3.6% | 1.32% | +1.6% |
Q3 2013 | $1,575,238,000 | +2.0% | 31,398 | +1.6% | 1.30% | -7.5% |
Q2 2013 | $1,543,873,000 | – | 30,896 | – | 1.41% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |